Detalles de la búsqueda
1.
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Haematologica
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634126
2.
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
Cancer Immunol Immunother
; 66(2): 233-245, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530271
3.
A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
Br J Haematol
; 174(5): 700-10, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118319
4.
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
Cancer Immunol Immunother
; 65(4): 453-63, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26059279
5.
Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.
Cytokine
; 61(3): 885-91, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357299
6.
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Immunol Cell Biol
; 90(1): 109-15, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383766
7.
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
Cancer Immunol Immunother
; 60(8): 1195-205, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21644031
8.
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Blood
; 113(4): 775-83, 2009 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18945964
9.
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
Blood
; 112(8): 3130-4, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18664623
10.
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia.
Cancers (Basel)
; 12(8)2020 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32764229
11.
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Haematologica
; 94(9): 1242-9, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608685
12.
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
Cancers (Basel)
; 11(6)2019 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31234588
13.
Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
Blood Coagul Fibrinolysis
; 19(5): 333-40, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18600079
14.
In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.
Front Immunol
; 8: 931, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28824651
15.
Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation.
Ann Hematol
; 87(11): 937-8, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18521601
16.
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
Blood
; 111(7): 3395-402, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18195095
Resultados
1 -
16
de 16
1
Próxima >
>>